ArticleInternational journal of cancer2018

A phosphoarray platform is capable of personalizing kinase inhibitor therapy in head and neck cancers.

Konrad Klinghammer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.